Subscribe: WSJ.com: Health
http://online.wsj.com/xml/rss/3_7089.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
care act  care  companies  drug  gop health  gop  health care  health plan  health  johnson johnson  johnson  new  plan  republican  year 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: WSJ.com: Health

WSJ.com: Health



Health



Last Build Date: Sat, 25 Mar 2017 00:30:27 EDT

Copyright: copyright © 2017 Dow Jones & Company, Inc.
 



A Prescription Blood Thinner Beat Aspirin at Preventing Recurrence of Blood Clots, Study Finds

Sun, 19 Mar 2017 17:40:20 EDT

A Canadian research team found low doses of the blood thinner rivaroxaban, marketed as Xarelto from Johnson & Johnson unit Janssen Pharmaceuticals, reduced the risk of blood clot recurrence by about 70% compared with aspirin, without increasing the risk of bleeding.



Ryan Confident About Health Plan's Passage

Mon, 20 Mar 2017 10:52:13 EDT

Paul Ryan expressed confidence that the Republican health-care plan will pass the House later this week, saying his party’s lawmakers are working to make changes to the bill to address remaining concerns, including providing more assistance to older Americans.



Young People to Pay Less Under GOP Health Plan, CBO Says

Tue, 14 Mar 2017 23:11:20 EDT

A federal analysis of a Republican health plan that shows it would leave millions more uninsured has a silver lining for GOP leaders: In general, premiums under their proposal would eventually come down for younger people.



GOP Senators Say House Health Bill Won't Pass Without Changes

Wed, 15 Mar 2017 18:24:52 EDT

Republican senators, alarmed by a nonpartisan report showing millions would lose insurance under the GOP health-care plan, warned Tuesday that the bill wouldn’t become law without fundamental changes.



After CBO Report, Democrats See Opening on Health Care

Tue, 14 Mar 2017 20:09:27 EDT

Democrats, after playing defense on health care for nearly a decade, are trying to turn the issue to their advantage in next year’s midterm elections, targeting in particular lawmakers who have already voted for the GOP health bill.



FDA Panel: Painkiller Opana ER Benefits No Longer Outweigh Risks

Tue, 14 Mar 2017 21:28:12 EDT

The benefits of an opioid painkiller linked to a 2015 HIV outbreak in Indiana no longer outweigh the risks, a panel of advisers to the U.S. Food and Drug Administration concluded Tuesday.



Generic Drugmakers Can Live With a Speedier FDA

Wed, 15 Mar 2017 08:58:50 EDT

FDA chief nominee Scott Gottlieb’s changes may pressure generic drug prices, but there are other positives for the sector.



CBO Sees 24 Million More Uninsured, $337 Billion Deficit Cut With GOP Plan

Tue, 14 Mar 2017 16:39:32 EDT

The number of Americans without health insurance would grow by 24 million under a House Republican proposal to topple most of the Affordable Care Act, according to a nonpartisan report that is likely to complicate GOP lawmakers’ efforts to unite around the plan.



Pershing Square Sold Stake in Valeant

Tue, 14 Mar 2017 09:26:00 EDT

William Ackman’s Pershing Square sold its stake in struggling drugmaker Valeant Pharmaceuticals, taking a roughly $4 billion loss and bringing to a close one of the most tortured sagas in hedge-fund history.



AstraZeneca Gives Rejected Drugs a Second Life

Tue, 14 Mar 2017 04:32:20 EDT

AstraZeneca is working with outside researchers to look for untapped potential in drugs that the company has shelved, part of a broader move to improve its research-and-development output.



Seema Verma Confirmed as Head of Centers for Medicare and Medicaid Services

Mon, 13 Mar 2017 19:04:27 EDT

Seema Verma, President Donald Trump’s pick to oversee the Medicare and Medicaid programs, won Senate confirmation in a largely party-line vote Monday, placing an advocate of overhauling Medicaid at the program’s helm.



After Record Year for Fatal Overdoses, New York City Targets Opioids

Mon, 13 Mar 2017 21:44:53 EDT

New York City will spend $38 million annually to combat an opioid epidemic that killed more than 1,000 New Yorkers last year, city officials said Monday.



GOP Health Plan Would Hit Rural Areas Hard

Mon, 13 Mar 2017 14:25:06 EDT

The House Republican effort to overhaul the Affordable Care Act could hit many rural areas particularly hard, sharply increasing the cost for some residents buying their own insurance.



Soda Loses Its U.S. Crown: Americans Now Drink More Bottled Water

Thu, 09 Mar 2017 20:31:52 EST

Americans now officially drink more bottled water than soda. It’s a shift that decades ago might have seemed unthinkable—that consumers would buy a packaged version of something that was free from a tap.



Health-Care Companies See Big Risks in Plan to Replace Obamacare

Wed, 08 Mar 2017 07:36:10 EST

Though they are applauding the elimination of some taxes, insurers foresee problems from the cancellation of penalties for going without health coverage.



Race Tightens for Next Wave of Cancer Drugs

Tue, 07 Mar 2017 20:39:55 EST

Incyte, which operates out of an old department store in Delaware, is one of the closest to market with a new class of immunotherapies.



Alliance of Companies Unveil First Steps to Cutting Health-Care Costs

Tue, 07 Mar 2017 23:33:19 EST

A U.S. alliance formed last year by more than three dozen companies, including American Express Co., Johnson & Johnson and Macy’s Inc., is announcing its first plans aimed at lowering the companies’ health-care spending.



Lawmaker Tries to Steer Through Tricky Terrain on ACA

Mon, 06 Mar 2017 20:36:16 EST

As Republicans dive into their politically risky push to undo the Affordable Care Act, Rep. Greg Walden is emerging as a key figure in the party’s attempt to rally around a new health-insurance system.



Bird Flu Found at Farm Affiliated With Tyson

Mon, 06 Mar 2017 14:28:16 EST

The first case of highly pathogenic avian influenza to strike a commercial poultry flock in more than a year has been found on a Tennessee chicken farm affiliated with Tyson Foods.



Marathon Faces Scrutiny for Price of Muscular Dystrophy Drug

Mon, 06 Mar 2017 09:57:21 EST

A group of U.S. senators is examining Marathon Pharmaceuticals LLC’s decision to charge $89,000 in the U.S. for an old steroidal drug that costs a fraction of that overseas, the latest sign of growing scrutiny of the company.



New Jersey Complex Finds New Life as a Home for Several Firms

Sun, 05 Mar 2017 21:04:51 EST

A 110-acre research complex in Bridgewater, N.J., seemed poised a few years ago to join the growing ranks of suburban office campuses left for dead, but a joint venture of investors is breathing life into the property.



Actelion's Founding Couple Starts New Biotech, With J&J's Backing

Fri, 03 Mar 2017 03:51:42 EST

The founders of Swiss biotech company Actelion, which has been sold to J&J, are starting over again—creating a new biotech player with nearly $1 billion in capital, a deep-pocketed partner in J&J and soon, a stock listing in Zurich.



Roche Shares Boosted by Cancer Drug Trial Success

Thu, 02 Mar 2017 10:11:39 EST

Roche shares rose sharply after the company reported a clinical trial success that could help cushion it against looming competition for Herceptin and boost sales for its newer Perjeta drug.



Drug Companies Block Shareholders' Voting on Price Transparency

Thu, 02 Mar 2017 10:12:19 EST

Several major U.S. drug companies, including Pfizer and Merck, have squelched an investor campaign aimed at forcing companies to disclose more information about when and why they raise prices.



Johnson & Johnson Prescription Unit List Prices Rose 8.5% Last Year

Mon, 27 Feb 2017 17:07:50 EST

Johnson & Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year—and 3.5% after discounts—in the health-products company’s first effort to address criticism about the high cost of medicines by opening up about its drug-pricing practices.